The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess the survival impact of initial disease distribution on patients with stage III epithelial ovarian cancer (EOC) cytoreduced to microscopic residual.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Gynecol. Oncol.

Title: Gynecologic oncology

Publisher: Elsevier BV

ISSN (Electronic): 1095-6859

ISSN (Print): 0090-8258

Publication date (Electronic): Sep 2011

Volume: 122

Issue: 3

Affiliations

[1 ] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, DC 20307-5001, USA. chad.a.hamilton@gmail.com

Article

Publisher Item ID: S0090-8258(11)00342-8 Mid ID: NIHMS433756

DOI: 10.1016/j.ygyno.2011.04.041

PMC ID: 3670691

PubMed ID: 21683993

SO-VID: 71e09e77-53ff-416e-b682-370c6cb5fea2

History

Data availability:

Comments

Comment on this article

scite_

Cited by 13

See all cited by